Cargando…
NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma
INTRODUCTION: Improving treatments for Diffuse Large B-Cell Lymphoma (DLBCL) is challenged by the vast heterogeneity of the disease. Nuclear factor-κB (NF-κB) is frequently aberrantly activated in DLBCL. Transcriptionally active NF-κB is a dimer containing either RelA, RelB or cRel, but the variabil...
Autores principales: | Jayawant, Eleanor, Pack, Arran, Clark, Heather, Kennedy, Emma, Ghodke, Ankur, Jones, John, Pepper, Chris, Pepper, Andrea, Mitchell, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272839/ https://www.ncbi.nlm.nih.gov/pubmed/37333821 http://dx.doi.org/10.3389/fonc.2023.1181660 |
Ejemplares similares
-
Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
por: Paul, Andrew, et al.
Publicado: (2018) -
NF-kB and the CLL microenvironment
por: O’Donnell, Alice, et al.
Publicado: (2023) -
Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma
por: Burley, Thomas A., et al.
Publicado: (2022) -
NF-κB Mutations in Germinal Center B-Cell Lymphomas: Relation to NF-κB Function in Normal B Cells
por: Pasqualucci, Laura, et al.
Publicado: (2022) -
Characterizing the role of the alternative NF-κB pathway in diffuse large B-cell lymphoma
por: Ito, Daisuke, et al.
Publicado: (2013)